| Literature DB >> 27488349 |
Daniel A Lichtenstein1, Andrew W Crispin1, Anoop K Sendamarai1, Dean R Campagna1, Klaus Schmitz-Abe2, Cristovao M Sousa3, Martin D Kafina4, Paul J Schmidt1, Charlotte M Niemeyer5, John Porter6, Alison May7, Mrinal M Patnaik8, Matthew M Heeney9, Alec Kimmelman10, Sylvia S Bottomley11, Barry H Paw4, Kyriacos Markianos1, Mark D Fleming1.
Abstract
The congenital sideroblastic anemias (CSAs) are a heterogeneous group of inherited blood disorders characterized by pathological mitochondrial iron deposition in erythroid precursors. Each known cause has been attributed to a mutation in a protein associated with heme biosynthesis, iron-sulfur cluster biogenesis, mitochondrial translation, or a component of the mitochondrial respiratory chain. Here, we describe a recurring mutation, c.276_278del, p.F93del, in NDUFB11, a mitochondrial respiratory complex I-associated protein encoded on the X chromosome, in 5 males with a variably syndromic, normocytic CSA. The p.F93del mutation results in respiratory insufficiency and loss of complex I stability and activity in patient-derived fibroblasts. Targeted introduction of this allele into K562 erythroleukemia cells results in a proliferation defect with minimal effect on erythroid differentiation potential, suggesting the mechanism of anemia in this disorder.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27488349 PMCID: PMC5064715 DOI: 10.1182/blood-2016-05-719062
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113